All patients should have access to effective and safe pain treatment options to achieve their optimal health. The Centers for Disease Control and Prevention (CDC) support the clinician-patient relationship in providing personalized pain management solutions.
The 2022 CDC Clinical Practice Guideline provides 12 voluntary recommendations for managing acute, subacute, and chronic pain. The guideline is not applicable to pain management related to sickle cell disease, cancer-related pain treatment, palliative care or end-of-life care.
During this COCA Call, the presenter will discuss CDC recommendations, implementation principles, and approaches to maximize benefits and minimize risks when starting, continuing, or discontinuing opioids for pain.
Thursday, November 17, 2022 I 1:00- 2:00 PM CT
At the conclusion of the session, the participant will be able to:
- Cite background information on the topic covered during the presentation.
- Discuss CDC’s role in the topic covered during the presentation.
- Describe the topic’s implications for clinicians.
- Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.
Presenter: Deborah Dowell, MD, MPH, CAPT, USPHS, Chief Clinical Research Officer, Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention